Cara Therapeutic (CARA) Annual Income Statement (USD)
CARA Quarterly Financials (USD)
Frequently Asked Questions About Cara Therapeutic (CARA) Stock
Cara Therapeutic's (CARA) last reported annual revenue was USD 20.97 Million.
Cara Therapeutic's (CARA) annual revenue growth rate based on the revenue reported in the past 5 years is : 9.26%
Cara Therapeutic's(CARA) is not profitable as of its last reported annual financials.
The net profit margin for Cara Therapeutic's(CARA) from its laster reported year is -565.21%
The return on equity (ROE) for Cara Therapeutic's(CARA) from its last reported annual financials is : -109.80%
The return on assets (ROA) for Cara Therapeutic's(CARA) from its last reported annual financials is : -49.30%
The return on invested capital (ROIC) for Cara Therapeutic's(CARA) from its last reported annual financials is : -112.57%
The Debt to Equity ratio for Cara Therapeutic's(CARA) from its last reported annual financials is : 0.00%
The dividend yield for Cara Therapeutic's(CARA) from its laster reported year is 0.00%
Cara Therapeutic's(CARA) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CARA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
